Back to Authors

Fan, Jenna

A5103832890 | I4210117619

Mayo Clinic

Novartis (United States)

Citations 2

PILLAR-2: A randomized, double-blind, placebo-controlled, phase III study of adjuvant everolimus (EVE) in patients (pts) with poor-risk diffuse large B-cell lymphoma (DLBCL).

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7506-7506

10.1200/jco.2016.34.15_suppl.7506

Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study

British Journal of Haematology | March 3, 2014 | Volume: 165 | Issue: 4 | Pages: 510-518

10.1111/bjh.12780 | PMID 24579926